Shanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion

Reuters03-27

Shanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion

Shanghai INT Medical Instruments published an annual results announcement for the year ended Dec. 31, 2025.
Revenue rose 25.06% to RMB1.1 billion, driven by an increase in new customers and a business combination.
Gross profit increased 18.44% to RMB636.8 million, while gross margin fell to 59.77% from 63.11%.
Profit for the year climbed 22.43% to RMB232.7 million, and basic earnings per share increased 14.55% to RMB1.26.
The board recommended a final dividend of RMB0.23 per share (equivalent to HKD0.26 per share) for 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Int Medical Instruments Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12073171), on March 27, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622966825?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 19:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622966825","market":"us","top_or_hot":-1,"title":"Shanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Shanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Shanghai INT Medical Instruments published an annual results announcement for the year ended Dec. 31, 2025.\n        </li>\n<li>\n          Revenue rose 25.06% to RMB1.1 billion, driven by an increase in new customers and a business combination.\n        </li>\n<li>\n          Gross profit increased 18.44% to RMB636.8 million, while gross margin fell to 59.77% from 63.11%.\n        </li>\n<li>\n          Profit for the year climbed 22.43% to RMB232.7 million, and basic earnings per share increased 14.55% to RMB1.26.\n        </li>\n<li>\n          The board recommended a final dividend of RMB0.23 per share (equivalent to HKD0.26 per share) for 2025.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai <a href=\"https://laohu8.com/S/01501\">Int Medical</a> Instruments Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12073171), on March 27, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-27 19:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Shanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Shanghai INT Medical Instruments published an annual results announcement for the year ended Dec. 31, 2025.\n        </li>\n<li>\n          Revenue rose 25.06% to RMB1.1 billion, driven by an increase in new customers and a business combination.\n        </li>\n<li>\n          Gross profit increased 18.44% to RMB636.8 million, while gross margin fell to 59.77% from 63.11%.\n        </li>\n<li>\n          Profit for the year climbed 22.43% to RMB232.7 million, and basic earnings per share increased 14.55% to RMB1.26.\n        </li>\n<li>\n          The board recommended a final dividend of RMB0.23 per share (equivalent to HKD0.26 per share) for 2025.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai <a href=\"https://laohu8.com/S/01501\">Int Medical</a> Instruments Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12073171), on March 27, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01501","symbol_name":"瑛泰医疗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL7q8SLY:1","article_id":"2622966825","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622966825","pubTimestamp":1774611182,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Shanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion. Shanghai INT Medical Instruments published an annual results announcement for the year ended Dec. 31, 2025.Revenue rose 25.06% to RMB1.1 billion, driven by an increase in new customers and a business combination.Gross profit increased 18.44% to RMB636.8 million, while gross margin fell to 59.77% from 63.11%.Profit for the year climbed 22.43% to RMB232.7 million, and basic earnings per share increased 14.55% to RMB1.26.The board recommended a final dividend of RMB0.23 per share  for 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Int Medical Instruments Co. Ltd. published the original content","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01501":"瑛泰医疗","BK1222":"医疗保健用品"},"translate_title":"上海英特医疗器械2025财年全年利润攀升22.43%至人民币2.33亿元；收入增长25.06%至人民币11亿元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01501":0.9},"content_text":"Shanghai INT Medical Instruments FY2025 profit for the year climbs 22.43% to RMB233 million; revenue grows 25.06% to RMB1.1 billion\n    \n\n\n          Shanghai INT Medical Instruments published an annual results announcement for the year ended Dec. 31, 2025.\n        \n\n          Revenue rose 25.06% to RMB1.1 billion, driven by an increase in new customers and a business combination.\n        \n\n          Gross profit increased 18.44% to RMB636.8 million, while gross margin fell to 59.77% from 63.11%.\n        \n\n          Profit for the year climbed 22.43% to RMB232.7 million, and basic earnings per share increased 14.55% to RMB1.26.\n        \n\n          The board recommended a final dividend of RMB0.23 per share (equivalent to HKD0.26 per share) for 2025.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Int Medical Instruments Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12073171), on March 27, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622966825","isCrawlerRequest":true}